Sign In
Buy DNLI
$19.66
+0.310 (+1.60%)
At Close: Jun 03, 2026
The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut
01:30pm, Wednesday, 29'th Jan 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 28) 10X Genomics Inc (NASDAQ: TXG ) Acceleron Pharma I
Denali Therapeutics (NASDAQ:DNLI) Stock Rating Upgraded by Goldman Sachs Group
07:26am, Wednesday, 29'th Jan 2020
Goldman Sachs Group upgraded shares of Denali Therapeutics (NASDAQ:DNLI) from a neutral rating to a buy rating in a report published on Sunday, BenzingaRatingsTable reports. Goldman Sachs Group curren
Denali Therapeutics Announces Pricing of Public Offering of Common Stock
01:58am, Wednesday, 29'th Jan 2020
Denali Therapeutics Inc. (DNLI) today announced the pricing of its underwritten public offering of 7,826,087 shares of its common stock at a price to the public of $23.00 per share. All of the shares
Denali Therapeutics Announces Pricing of Public Offering of Common Stock
01:58am, Wednesday, 29'th Jan 2020
SOUTH SAN FRANCISCO, Calif., Jan. 28, 2020 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI) today announced the pricing of its underwritten...
AVEO Posts Data on Ficlatuzumab From Pancreatic Cancer Study
04:14pm, Tuesday, 28'th Jan 2020
AVEO releases results from a phase Ib study on ficlatuzumab in combination with nab-paclitaxel and gemcitabine for treating advanced pancreatic cancer. Shares inch up.
AVEO Posts Data on Ficlatuzumab From Pancreatic Cancer Study
03:39pm, Tuesday, 28'th Jan 2020
AVEO releases results from a phase Ib study on ficlatuzumab in combination with nab-paclitaxel and gemcitabine for treating advanced pancreatic cancer. Shares inch up.
AVEO Posts Data on Ficlatuzumab From Pancreatic Cancer Study
03:39pm, Tuesday, 28'th Jan 2020
AVEO releases results from a phase Ib study on ficlatuzumab in combination with nab-paclitaxel and gemcitabine for treating advanced pancreatic cancer. Shares inch up.
7 Big Biotech Stocks to Avoid
02:46pm, Tuesday, 28'th Jan 2020
The only thing more important than what to buy is what not to buy. These biotech stocks are at the top of the avoid list. Here's why.
The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics
12:12pm, Tuesday, 28'th Jan 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 27) 10X Genomics Inc (NASDAQ: TXG ) Achillion Pharmace
Analysts' Downgrades for January, 28th (ABBV, ACHC, ALGN, AMAT, ARGKF, ARWR, ATRC, ATVI, BGNE, BPFH)
08:26am, Tuesday, 28'th Jan 2020
Analysts’ downgrades for Tuesday, January 28th: AbbVie (NYSE:ABBV) was downgraded by analysts at ValuEngine from a hold rating to a sell rating. Acadia Healthcare (NASDAQ:ACHC) was downgraded by ana
Denali Therapeutics Announces Proposed Offering of Common Stock
09:10pm, Monday, 27'th Jan 2020
Denali Therapeutics Inc. (DNLI) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering of $150 million of shares of its common stock. In addit
Franklin Electric boosts quarterly dividend 7% FELE
03:59pm, Monday, 27'th Jan 2020
Franklin Electric boosts quarterly dividend 7% FELE
J&J CEO says he didn't read all asbestos in talc documents, Reuters reports JNJ
03:41pm, Monday, 27'th Jan 2020
J&J CEO says he didn't read all asbestos in talc documents, Reuters reports JNJ
